HopeStage
Back to all studies
RecruitingNCT06712602

PT150 and the effects of stress and alcohol in people with alcohol use disorder

About this title

PT150 Drug for Use in Alcohol Use Disorder

Read the official source — NCT06712602
Medication studyAges 21–55United StatesAddiction
The study in practice

Understand this study

Who could participate?

Listed age limits: 21 years to 55 years.

Listed locations
LexingtonSee all locations and recruitment
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: February 1, 2025
Recruitment status
Recruiting
Enrollment listed in the registry
34
Sponsor
Pop Test Oncology LLC
Sponsor type
Other organization
Study type
Behavioral
Intervention type
Behavioural, Drug
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Locations
United States
Age range
From 21 Years to 55 Years
Official registry ID
NCT06712602
Official title
Show the full official title

Selective Glucocorticoid Receptor Antagonism in Alcohol Use Disorder: A Human Laboratory Study

Recruitment & locations

Currently recruiting

Lexington

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Pop Test Oncology LLC.

Does this study involve medication?

Yes. The study involves medication, including alcohol and PT150.

Who can participate?

Listed age limits: 21 years to 55 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies